FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153281303> ?p ?o ?g. }

• W2153281303 endingPage "291" @default.
• W2153281303 startingPage "285" @default.
• W2153281303 abstract "<em>AIM</em>: To determine induced sputum cell counts and interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-&#945;) and leukotriene B₄ (LTB₄) levels as markers of neutrophilic inflammation in moderate persistent asthma, and to evaluate the response to inhaled steroid therapy.<em>Methods</em>: Forty-five moderate asthmatic patients and 10 non-smoker controls were included in this study. All patients received inhaled corticosteroid (800 &#956;g of budesonide) for 12 weeks. Before and after treatment pulmonary function tests were performed, and symptom scores were determined. Blood was drawn for analysis of serum inflammatory markers, and sputum was induced.<em>Results</em>: Induced sputum cell counts and inflammatory markers were significantly higher in patients with asthma than in the control group. The induced sputum eosinophil counts of 12 patients (26%) were found to be less than 5%, the non-eosinophilic group, and sputum neutrophil counts, IL-8 and TNF-&#945; levels were significantly higher than the eosinophilic group (neutrophil, 50&#177;14% versus 19&#177;10%, <mml:math alttext=$p &#60; 0.01$ xmlns:mml=http://www.w3.org/1998/Math/MathML><mml:mi>p</mml:mi><mml:mo>&#60;</mml:mo><mml:mn>0.01</mml:mn></mml:math>). In both groups, there was a significant decrease in sputum total cell counts and serum and sputum IL-8, TNF-&#945; and LTB₄ levels after the treatment. There was no change in sputum neutrophil counts. Although the sputum eosinophil count decreased only in the eosinophilic subjects, there was no significant difference in inflammatory markers between the groups. The symptom scores were significantly improved after treatment, while the improvement did not reach statistical significance on pulmonary function test parameters.<em>Conclusion</em>: Notably, in chronic asthma there is a subgroup of patients whose predominant inflammatory cells are not eosinophils. Sputum neutrophil counts and neutrophilic inflammatory markers are significantly higher in these patients. In the non-eosinophilic group, inhaled steroid caused an important decrease in inflammatory markers; however, there was no change in the sputum eosinophil and neutrophil counts." @default.
• W2153281303 created "2016-06-24" @default.
• W2153281303 creator A5024987637 @default.
• W2153281303 creator A5028944764 @default.
• W2153281303 creator A5062214061 @default.
• W2153281303 creator A5080153958 @default.
• W2153281303 creator A5089403961 @default.
• W2153281303 date "2004-01-01" @default.
• W2153281303 modified "2023-10-16" @default.
• W2153281303 title "Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients" @default.
• W2153281303 cites W1736073447 @default.
• W2153281303 cites W1968723792 @default.
• W2153281303 cites W1975847098 @default.
• W2153281303 cites W1979513219 @default.
• W2153281303 cites W1990674750 @default.
• W2153281303 cites W1993997407 @default.
• W2153281303 cites W1995033048 @default.
• W2153281303 cites W1995124093 @default.
• W2153281303 cites W2003199954 @default.
• W2153281303 cites W2014738267 @default.
• W2153281303 cites W2044177071 @default.
• W2153281303 cites W2047359372 @default.
• W2153281303 cites W2049528988 @default.
• W2153281303 cites W2066880035 @default.
• W2153281303 cites W2082908101 @default.
• W2153281303 cites W2097681404 @default.
• W2153281303 cites W2105769151 @default.
• W2153281303 cites W2109781176 @default.
• W2153281303 cites W2114770406 @default.
• W2153281303 cites W2117159720 @default.
• W2153281303 cites W2121804671 @default.
• W2153281303 cites W2121892537 @default.
• W2153281303 cites W2140775892 @default.
• W2153281303 cites W2157801619 @default.
• W2153281303 cites W2158548490 @default.
• W2153281303 cites W2159638894 @default.
• W2153281303 cites W2167950725 @default.
• W2153281303 doi "https://doi.org/10.1080/09629350400003118" @default.
• W2153281303 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1781566" @default.
• W2153281303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15545060" @default.
• W2153281303 hasPublicationYear "2004" @default.
• W2153281303 type Work @default.
• W2153281303 sameAs 2153281303 @default.
• W2153281303 citedByCount "28" @default.
• W2153281303 countsByYear W21532813032012 @default.
• W2153281303 countsByYear W21532813032013 @default.
• W2153281303 countsByYear W21532813032014 @default.
• W2153281303 countsByYear W21532813032015 @default.
• W2153281303 countsByYear W21532813032016 @default.
• W2153281303 countsByYear W21532813032017 @default.
• W2153281303 countsByYear W21532813032018 @default.
• W2153281303 countsByYear W21532813032019 @default.
• W2153281303 countsByYear W21532813032020 @default.
• W2153281303 countsByYear W21532813032023 @default.
• W2153281303 crossrefType "journal-article" @default.
• W2153281303 hasAuthorship W2153281303A5024987637 @default.
• W2153281303 hasAuthorship W2153281303A5028944764 @default.
• W2153281303 hasAuthorship W2153281303A5062214061 @default.
• W2153281303 hasAuthorship W2153281303A5080153958 @default.
• W2153281303 hasAuthorship W2153281303A5089403961 @default.
• W2153281303 hasBestOaLocation W21532813031 @default.
• W2153281303 hasConcept C126322002 @default.
• W2153281303 hasConcept C142724271 @default.
• W2153281303 hasConcept C203014093 @default.
• W2153281303 hasConcept C2776042228 @default.
• W2153281303 hasConcept C2776301714 @default.
• W2153281303 hasConcept C2776804153 @default.
• W2153281303 hasConcept C2777037409 @default.
• W2153281303 hasConcept C2779758542 @default.
• W2153281303 hasConcept C2781069245 @default.
• W2153281303 hasConcept C71924100 @default.
• W2153281303 hasConcept C88675164 @default.
• W2153281303 hasConcept C90924648 @default.
• W2153281303 hasConceptScore W2153281303C126322002 @default.
• W2153281303 hasConceptScore W2153281303C142724271 @default.
• W2153281303 hasConceptScore W2153281303C203014093 @default.
• W2153281303 hasConceptScore W2153281303C2776042228 @default.
• W2153281303 hasConceptScore W2153281303C2776301714 @default.
• W2153281303 hasConceptScore W2153281303C2776804153 @default.
• W2153281303 hasConceptScore W2153281303C2777037409 @default.
• W2153281303 hasConceptScore W2153281303C2779758542 @default.
• W2153281303 hasConceptScore W2153281303C2781069245 @default.
• W2153281303 hasConceptScore W2153281303C71924100 @default.
• W2153281303 hasConceptScore W2153281303C88675164 @default.
• W2153281303 hasConceptScore W2153281303C90924648 @default.
• W2153281303 hasIssue "4" @default.
• W2153281303 hasLocation W21532813031 @default.
• W2153281303 hasLocation W21532813032 @default.
• W2153281303 hasLocation W21532813033 @default.
• W2153281303 hasLocation W21532813034 @default.
• W2153281303 hasLocation W21532813035 @default.
• W2153281303 hasOpenAccess W2153281303 @default.
• W2153281303 hasPrimaryLocation W21532813031 @default.
• W2153281303 hasRelatedWork W1997095217 @default.
• W2153281303 hasRelatedWork W1997827344 @default.
• W2153281303 hasRelatedWork W2014078838 @default.
• W2153281303 hasRelatedWork W2053208368 @default.
• W2153281303 hasRelatedWork W2101825616 @default.

• next